Bacterial keratitis. Keratitis
Conditions
Interventions
Intervention 1: Control group: Treatment using standard antibiotic eye drops (ceftazidime + vancomycin). Intervention 2: Treatment is done using standard antibiotic eye drops (ceftazidime + vancomycin
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with bacterial keratitis caused by Staphylococcus aureus or Pseudomonas aeruginosa Having consent to enter the study
Exclusion criteria
Exclusion criteria: The patient's lack of consent to continue the examinations Occurrence of any unusual side effects Infectious keratitis of fungal origin Spread of infection to other parts of the eye Having systemic immunodeficiency Having a cornea transplant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Keratitis infection. Timepoint: 3, 7, and 14 days after drug administration. Method of measurement: Microscopic evaluation using Slit lamp.;Treatment duration. Timepoint: 3, 7, and 14 days after drug administration. Method of measurement: Microscopic evaluation using Slit lamp. | — |
Secondary
| Measure | Time frame |
|---|---|
| Corneal opacity. Timepoint: 7, 14, 30 and 90 days. Method of measurement: Microscopic evaluation using Slit lamp.;Pain and burning. Timepoint: 7, 14, 30 and 90 days. Method of measurement: Microscopic evaluation using Slit lamp.;Shedding tears. Timepoint: Macroscopic and microscopic evaluation using Slit lamp. Method of measurement: 7, 14, 30 and 90 days.;Eye redness. Timepoint: 7, 14, 30 and 90 days. Method of measurement: Macroscopic and microscopic evaluation using Slit lamp.;Eye inflammation. Timepoint: 7, 14, 30 and 90 days. Method of measurement: Microscopic evaluation using slit lamp. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrdad Moosazadeh Moghaddam
Bagheiat-allah University of Medical Sciences
Outcome results
None listed